GEFTINAT 250mg (Gefitinib) is a prescription drug used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer. It interferes with the growth and spread of cancer cells in the body.
Manufacturer : Natco Pharma Ltd.
Strengths available : 250 mg tablets
Storage : Store in a cool, dry place, protected from light and moisture
- The recommended daily dose of GeftiNat (Iressa or Gefitinib) is one 250 mg tablet with or without food.
- Higher doses do not give a better response and cause increased toxicity.
Most common side effects are Nausea, Rash, Vomiting, Weakness, Loss of appetite, Dry skin, Diarrhoea, Stomatitis (Inflammation of the mouth).